Translated automatically – community improvements welcome.
(2S)-1-phenylpropan-2-amine
Dextroamphetamine are centrally acting stimulants that primarily work through the release and inhibition of the reuptake of dopamine and norepinephrine. They are medically used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. Side effects may include cardiovascular strain and potential for dependence. The substance primarily affects dopaminergic and noradrenergic systems in the brain.
Mechanism of Action
- Dopaminfreisetzung
- Noradrenalinfreisetzung
- Wiederaufnahmehemmung
Names / Identifiers
IUPAC: Dextroamphetamine
Mechanism of Action
Dextroamphetamin wirkt hauptsächlich als Dopamin- und Noradrenalin-Wiederaufnahmehemmer, was zu einer erhöhten Verfügbarkeit dieser Neurotransmitter im synaptischen Spalt führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Cardiovascular diseases
- Hypertension
- Schizophrenia
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Schlaflosigkeit, erhöhter Herzschlag und Angstzustände.
Safer Use
- Start at a low dose.
- Take regular breaks.
- Pay attention to physical reactions.
Harm reduction tips do not replace medical advice.
Known Interactions
- MAO inhibitors
- Serotonin reuptake inhibitors
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.
Gemeinsame Wirkungsmuster
Wirkungen, die (2S)-1-phenylpropan-2-amine mit verwandten Substanzen teilt.